Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
01 2Biophore India Pharmaceuticals Pvt Ltd
02 1ANDA Repository
03 1Amphastar Pharmaceuticals
04 1Annora Pharma
05 13Bayer AG
06 7Bracco
07 2Farmak JSC
08 8GE Healthcare Inc
09 5Mallinckrodt Pharmaceuticals
10 1Xian Libang Pharmaceutical Co.,Ltd
01 4AMP
02 1FOR SOLUTION;ORAL, RECTAL
03 18INJECTABLE;INJECTION
04 3Injection
05 3LIQ
06 1SOLUTION
07 6SOLUTION;ORAL, RECTAL
08 1SOLUTION;URETERAL
09 2Solution
10 2Solution for Injection
01 22DISCN
02 1Ethical
03 7Originator
04 4RX
05 7Blank
01 1ANGIOVIST 292
02 1ANGIOVIST 370
03 2DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM
04 1DIATRIZOATE-60
05 2GASTROGRAFIN
06 1GASTROVIST
07 3Gastrografin
08 4HYPAQUE
09 1HYPAQUE SODIUM 20%
10 1HYPAQUE-76
11 1HYPAQUE-M,75%
12 1HYPAQUE-M,90%
13 1MD-50
14 1MD-60
15 1MD-76
16 1MD-76R
17 1MD-GASTROVIEW
18 1RENOCAL-76
19 1RENOGRAFIN-60
20 1RENOGRAFIN-76
21 1RENOVIST
22 1RENOVIST II
23 2Triombrast
24 1UROVIST SODIUM 300
25 2Urografin 30%
26 2Urografin 60%
27 2Urografin 76%
28 3Blank
01 1Canada
02 1China
03 2India
04 7South Africa
05 2Switzerland
06 26USA
07 2Ukraine
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 76%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Diatrizoate Sodium; Diatrizoate Meglumine
Brand Name :
Dosage Form : Injection
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : RENOGRAFIN-76
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 66%;10%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : RENOGRAFIN-60
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 52%;8%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : RENOVIST II
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 28.5%;29.1%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : RENOVIST
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 34.3%;35%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : GASTROGRAFIN
Dosage Form : SOLUTION;ORAL, RECTAL
Dosage Strength : 66%;10%
Packaging :
Approval Date : 1982-01-01
Application Number : 11245
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYPAQUE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50%
Packaging :
Approval Date : 1982-01-01
Application Number : 9561
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYPAQUE SODIUM 20%
Dosage Form : SOLUTION;URETERAL
Dosage Strength : 20%
Packaging :
Approval Date : 1982-01-01
Application Number : 9561
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYPAQUE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 25%
Packaging :
Approval Date : 1982-01-01
Application Number : 9561
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : HYPAQUE-M,90%
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 60%;30%
Packaging :
Approval Date : 1982-01-01
Application Number : 10220
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : HYPAQUE-M,75%
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50%;25%
Packaging :
Approval Date : 1982-01-01
Application Number : 10220
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYPAQUE
Dosage Form : FOR SOLUTION;ORAL, RECTAL
Dosage Strength : 100%
Packaging :
Approval Date : 1982-01-01
Application Number : 11386
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYPAQUE
Dosage Form : SOLUTION;ORAL, RECTAL
Dosage Strength : 40%
Packaging :
Approval Date : 1982-01-01
Application Number : 11386
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : HYPAQUE-76
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 66%;10%
Packaging :
Approval Date : 1982-01-01
Application Number : 86505
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : MD-76R
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 66%;10%
Packaging :
Approval Date : 1989-09-29
Application Number : 19292
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : MD-76
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 66%;10%
Packaging :
Approval Date : 1982-01-01
Application Number : 87073
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : MD-60
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 52%;8%
Packaging :
Approval Date : 1982-01-01
Application Number : 87074
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MD-50
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50%
Packaging :
Approval Date : 1982-01-01
Application Number : 87075
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : MD-GASTROVIEW
Dosage Form : SOLUTION;ORAL, RECTAL
Dosage Strength : 66%;10%
Packaging :
Approval Date : 1982-01-01
Application Number : 87388
Regulatory Info : RX
Registration Country : USA
